Plasma Derivative
Zemaira NDC 0053-7201
- Generic Name
- Alpha-1-proteinase Inhibitor Human
- Dosage Form
- Kit
- Route
- Not available
Active Listing
Brand and Generic Alternatives
The similar products listed below help you identify alternative medications based on regulatory status, active ingredients, and administration routes. Identify therapeutic equivalents and alternative medications for Prolastin-c (NDC 13533-703). This cross-referenced list provides clinically relevant matches based on the following criteria:
- Generic Bioequivalence: Products sharing the generic name: Alpha-1-proteinase Inhibitor (human).
- Administration Consistency: Same Route () and Dosage Form (kit).
- Brand Alternatives: Different proprietary names for the same chemical entity.
Showing 10 similar products
Fisher Clinical Services Inc.
Plasma Derivative
Zemaira NDC 57516-101
- Generic Name
- Alpha-1-proteinase Inhibitor Human Kit
- Dosage Form
- Kit
- Route
- Intravenous
Active Listing
Plasma Derivative
Zemaira NDC 57516-110
- Generic Name
- Alpha-1-proteinase Inhibitor Human Kit
- Dosage Form
- Kit
- Route
- Intravenous
Active Listing
Plasma Derivative
Zemaira NDC 57516-113
- Generic Name
- Alpha-1-proteinase Inhibitor Human Kit
- Dosage Form
- Kit
- Route
- Intravenous
Active Listing
GRIFOLS USA, LLC
Plasma Derivative
Prolastin-c NDC 13533-700
- Generic Name
- Alpha-1-proteinase Inhibitor (human)
- Dosage Form
- Kit
- Route
- Not available
Active Listing
Plasma Derivative
Prolastin-c NDC 13533-706
- Generic Name
- Alpha-1-proteinase Inhibitor (human)
- Dosage Form
- Kit
- Route
- Not available
Active Listing
Takeda Pharmaceuticals America, Inc.
Plasma Derivative
Aralast NP NDC 0944-2814
- Generic Name
- Alpha-1-proteinase Inhibitor (human)
- Dosage Form
- Kit
- Route
- Not available
Active Listing
Plasma Derivative
Aralast NP NDC 0944-2815
- Generic Name
- Alpha-1-proteinase Inhibitor (human)
- Dosage Form
- Kit
- Route
- Not available
Active Listing
